Certolizumab Pegol: all 98 studies that test it

Page 1 of 1. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.

• Biologic Treatment Withdrawal in Takayasu Arteritis Patients in Sustained RemissionRecruitingNCT07491913Not applicable
• Utilization of a Microdevice for Psoriasis and Atopic DermatitisNot yet recruitingNCT07352566Phase 4
• Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder ArthroplastyRecruitingNCT07138898Phase 2
• Certolizumab in Recurrent Implantation Failure (RIF)RecruitingNCT05930613Phase 3
• Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic ArthritisRecruitingNCT04610476Phase 3
• Treatment of Rheumatoid Arthritis With DMARDs: Predictors of ResponseRecruitingNCT03414502Phase 3
• IMPACT Study: IMProve Pregnancy in APS With Certolizumab TherapyRecruitingNCT03152058Phase 2
• A Study to Assess the Pharmacokinetics of Certolizumab Pegol in Adults With Active Rheumatoid ArthritisCompletedNCT04740814Phase 1Results posted
• Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's DiseaseCompletedNCT03357471Phase 3Results posted
• A Study to Test the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Patients With Active Ankylosing SpondylitisCompletedNCT03215277Phase 2Results posted
• A Study to Test the Efficacy and Safety of Certolizumab Pegol in Japanese Subjects With Moderate to Severe Chronic PsoriasisCompletedNCT03051217Phase 2/3Results posted
• A Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis (AU) Flares in Axial Spondyloarthritis Subjects With a Documented History of AUCompletedNCT03020992Phase 4Results posted
• Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of ASCompletedNCT02552212Phase 3Results posted
• Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to PlaceboCompletedNCT02505542Phase 3Results posted
• Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial CystitisCompletedNCT02497976Phase 3Results posted
• IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIACompletedNCT02451748Phase 4Results posted
• Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)CompletedNCT02346240Phase 3Results posted
• An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)CompletedNCT02326298Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)CompletedNCT02326272Phase 3Results posted
• An Open-label Extension Study of Certolizumab Pegol in Chinese Patients With Rheumatoid Arthritis Who Enrolled in RA0044CompletedNCT02319642Phase 3Results posted
• A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating MothersCompletedNCT02154425Phase 1Results posted
• A Study of Certolizumab Pegol as Additional Therapy in Chinese Patients With Active Rheumatoid ArthritisCompletedNCT02151851Phase 3Results posted
• A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the PlacentaCompletedNCT02019602Phase 1Results posted
• Cimzia Versus Mesalamine for Crohn's RecurrenceTerminatedNCT01696942Phase 4Results posted
• Pediatric Arthritis Study of Certolizumab PegolCompletedNCT01550003Phase 3Results posted
• A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid ArthritisCompletedNCT01521923Phase 3Results posted
• A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid ArthritisCompletedNCT01519791Phase 3Results posted
• Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to MethotrexateCompletedNCT01500278Phase 4Results posted
• Efficacy Confirmation Study of CDP870 in Early Rheumatoid ArthritisCompletedNCT01451203Phase 3Results posted
• Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid ArthritisCompletedNCT01443364Phase 4Results posted
• Rheumatoid Arthritis Treatment and Biopsy Study Assessing Certolizumab Pegol (Cimzia)CompletedNCT01374971Phase 3Results posted
• A 12 Week Study to Assess Changes in Joint Inflammation Using Ultrasonography in Patients With Rheumatoid Arthritis (RA)TerminatedNCT01292265Phase 3Results posted
• A Comparison of Two Assessment Tools in Predicting Treatment Success of Cimzia in Rheumatoid Arthritis SubjectsCompletedNCT01255761Phase 4Results posted
• Magnetic Resonance Image Verified Early Response to Certolizumab Pegol in Subjects With Active Rheumatoid Arthritis (RA)CompletedNCT01235598Phase 3Results posted
• Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab PegolCompletedNCT01190410Phase 2Results posted
• Can TNF-Alpha Incomplete Secondary Responders Attain a Safe and Efficacious Response Switching to CimziaCompletedNCT01147341Phase 4Results posted
• Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic ArthritisCompletedNCT01087788Phase 3Results posted
• Certolizumab Pegol in Subjects With Active Axial SpondyloarthritisCompletedNCT01087762Phase 3Results posted
• Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal VaccinesCompletedNCT00993668Phase 4Results posted
• A Study of CDP870 as Add-on Meditation to Methotrexate (MTX) in Patients With Rheumatoid ArthritisCompletedNCT00993317Phase 3Results posted
• The Use of Certolizumab Pegol for Treatment of Active Crohn's Disease in Children and AdolescentsTerminatedNCT00899678Phase 2Results posted
• Long-term Treatment Study of Certolizumab Pegol (CDP870) as Add-on Medication to Methotrexate in Japanese Rheumatoid Arthritis (RA) PatientsCompletedNCT00851318Phase 3Results posted
• Long-term Treatment Study of Certolizumab Pegol Without Coadministration of Methotrexate in Japanese Rheumatoid Arthritis (RA) PatientsCompletedNCT00850343Phase 3Results posted
• Comparison Bioequivalence Study: Pre-filled Syringe (Reference) Versus Auto-injection Device (Test)CompletedNCT00845663Phase 1Results posted
• Follow-up of Rheumatoid Arthritis (RA) Moderate to Low Disease Activity StudyCompletedNCT00843778Phase 3Results posted
• Efficacy Confirmation Trial of CDP870 as add-on Medication to Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)CompletedNCT00791999Phase 2/3Results posted
• Efficacy Confirmation Trial of CDP870 Without Coadministration of Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)CompletedNCT00791921Phase 3Results posted
• Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA)CompletedNCT00753454Phase 3Results posted
• Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid ArthritisCompletedNCT00717236Phase 3Results posted
• Rheumatoid Arthritis (RA) Moderate to Low Disease Activity StudyCompletedNCT00674362Phase 3Results posted
• Dosing Flexibility Study in Patients With Rheumatoid ArthritisCompletedNCT00580840Phase 4Results posted
• A Study to Evaluate Safety of Long Term Therapy of Certolizumab Pegol Patients With Crohn's DiseaseCompletedNCT00552344Phase 3Results posted
• Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's DiseaseCompletedNCT00552058Phase 3Results posted
• Examining the Long Term Safety, Efficacy, and Corticosteroid-sparing Effect of Certolizumab Pegol in Crohn's DiseaseCompletedNCT00356408Phase 3Results posted
• Corticosteroid Sparing Effect of Certolizumab in Crohn's DiseaseTerminatedNCT00349752Phase 3Results posted
• Follow-up to Welcome Study C87042 [NCT00308581] Examining Certolizumab Pegol (CDP870) in Subjects With Crohn's DiseaseCompletedNCT00333788Phase 3Results posted
• Maintenance Study of Certolizumab Pegol (CZP) in Crohn's DiseaseCompletedNCT00329550Phase 2Results posted
• Maintenance Study Including Re-induction Therapy for Patients Who Did Not Show a Clinical Effect in Study C87037 (NCT00291668)CompletedNCT00329420Phase 2Results posted
• Efficacy of Re-treatment With Cimzia® in Subject With Chronic Plaque PsoriasisCompletedNCT00329303Phase 2Results posted
• Certolizumab in Crohn's Disease Patients With Loss of Response or Intolerance to InfliximabCompletedNCT00308581Phase 3Results posted
• Certolizumab Pegol for Treatment of Adult Greek Patients With Moderate to Severe Crohn's Disease Who Failed InfliximabTerminatedNCT00307931Phase 3Results posted
• Mucosal Healing Study in Crohn's Disease (CD)CompletedNCT00297648Phase 3Results posted
• Clinical Study of CDP870/Certolizumab Pegol in Patients With Active Crohn's DiseaseCompletedNCT00291668Phase 2Results posted
• Efficacy Study of CDP870 in Subjects With Chronic Plaque Psoriasis Who Are Candidate for Systemic Therapy and/or Phototherapy/PhotochemotherapyCompletedNCT00245765Phase 2Results posted
• A Study of the Safety and Effectiveness of Lyophilized Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid ArthritisCompletedNCT00175877Phase 3Results posted
• A follow-on Safety Study in Subjects With Crohn's Disease Who Have Previously Been Withdrawn From the Double-blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] Due to an Exacerbation of Crohn's DiseaseCompletedNCT00160706Phase 3Results posted
• Open Label Long-Term Safety Study of Certolizumab Pegol (CZP) for Patients With Rheumatoid ArthritisCompletedNCT00160693Phase 3Results posted
• A Study of the Safety and Effectiveness of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid ArthritisCompletedNCT00160641Phase 3Results posted
• A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]CompletedNCT00160524Phase 3Results posted
• A Study to Test Efficacy, Safety, and Pharmacokinetics of Certolizumab Pegol in Children and Adolescents With Moderately to Severely Active Crohn's DiseaseWithdrawnNCT04643483Phase 3
• Treatment of Pregnancy RAStatus unknownNCT04569890Not applicable
• A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT04123795Phase 3
• Does Clinical Response Correlate With Serum Certolizumab Levels?Status unknownNCT02597829Phase 4
• Long-term Treatment Study of CDP870 Self-injection in Patients With Active Rheumatoid Arthritis Who Are Participating in the Long-term Treatment Studies (Study 275-08-002 or Study 275-08-004) of CDP870CompletedNCT02586246Phase 3
• Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease ActivityStatus unknownNCT02466581Phase 4
• A Study of Certolizumab Pegol to Evaluate Pharmacokinetics and Safety in Adult Healthy Chinese SubjectsCompletedNCT02365948Phase 1
• RICE: Remission by Intra-articular Injection Plus CErtolizumabCompletedNCT02293590Phase 2
• Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing SpondylitisStatus unknownNCT02132234Phase 4
• Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung AdenocarcinomasCompletedNCT02120807Phase 1
• Prediction of Response to Certolizumab Pegol Treatment by Functional MRI of the BrainCompletedNCT01864265Phase 3
• Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose ReductionStatus unknownNCT01491815Phase 4
• SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug.CompletedNCT01295151Phase 4
• The Effect of Certolizumab Pegol on MRI Synovitis and Bone Edema in Rheumatoid Arthritis PatientsCompletedNCT01213017Phase 3
• Open-label, Extension Study of CDP870 in Patients With Rheumatoid ArthritisCompletedNCT01197066Phase 3
• Evaluation of the Effects of Certolizumab Pegol on Semen Quality in Healthy Male VolunteersCompletedNCT01091220Phase 1
• Study of Cimzia for the Treatment of Ulcerative ColitisCompletedNCT01090154Phase 2
• Assessment of Small Bowel Healing in Crohn's Disease Patients Treated With Cimzia Using Wireless Capsule EndoscopyCompletedNCT01053559Not applicable
• Optimizing Cimzia in Crohn's PatientsStatus unknownNCT01024647Phase 4
• Bio-availability Comparison of Three Formulations of Certolizumab Pegol in Healthy VolunteersCompletedNCT00813774Phase 1
• Efficacy and Safety of CDP870 Versus Placebo in the Treatment of the Signs and Symptoms of Rheumatoid ArthritisCompletedNCT00548834Phase 3
• Efficacy and Safety of CDP870 and Methotrexate Compared to Methotrexate Alone in Subjects With Rheumatoid ArthritisCompletedNCT00544154Phase 3
• A Trial Evaluating Safety of Chronic Therapy With Certolizumab Pegol in Crohn's DiseaseWithdrawnNCT00358683Phase 3
• Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining FistulasWithdrawnNCT00354367Phase 3
• A Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tablets in Children With Crohn´s DiseaseCompletedNCT00225810Phase 4
• A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid ArthritisCompletedNCT00160602Phase 3
• A Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo)CompletedNCT00152490Phase 3
• Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo), Following 3 Doses of Active Drug (CDP870).CompletedNCT00152425Phase 3
• A Placebo Controlled Study to Assess Efficacy and Safety of Certolizumab Pegol in the Treatment of Rheumatoid ArthritisCompletedNCT00152386Phase 3

← Certolizumab Pegol overview